Please check your internet connection and try again.
## Ecospirin (Aspirin, Enteric-Coated)
### Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. The enteric coating is designed to delay the absorption of aspirin until it reaches the small intestine, potentially reducing gastrointestinal irritation.
### Primary Indications
* **Cardioprotection/Secondary Prevention of Cardiovascular Events:** For patients with a history of myocardial infarction, stroke, transient ischemic attack (TIA), or peripheral arterial disease.
* **Primary Prevention of Cardiovascular Events:** In select individuals based on risk assessment (controversial and individualized).
* **Analgesia and Antipyresis:** For mild to moderate pain and fever.
* **Rheumatoid Arthritis and other Inflammatory Conditions:** At higher doses.
### Adult Dosing
* **Cardioprotection/Secondary Prevention:** 75 mg to 100 mg once daily.
* **Primary Prevention:** 75 mg to 100 mg once daily (use is individualized and guided by risk factors).
* **Analgesia/Antipyresis:** 325 mg to 650 mg every 4 to 6 hours as needed. Maximum daily dose typically 4000 mg.
* **Rheumatoid Arthritis:** Doses vary widely, often starting at 325 mg to 650 mg 3-4 times daily, with titration to 4000 mg to 6000 mg per day in divided doses.
Dosing for specific cardiovascular prevention strategies should follow established guidelines or local protocols.
### Pediatric Dosing
Aspirin is generally **not recommended** for children and adolescents due to the risk of Reye's syndrome, particularly during viral illnesses like influenza or chickenpox. Specific indications and dosing, if considered necessary, should be determined by a specialist.
### Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment, but caution is advised, especially with higher doses or in severe impairment, due to potential for exacerbation of renal dysfunction or bleeding.
### Contraindications
* Known hypersensitivity to aspirin or other NSAIDs.
* Children and teenagers with viral infections.
* Active peptic ulcer disease.
* Bleeding disorders.
* Severe renal or hepatic impairment.
* Third trimester of pregnancy.
### Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, peptic ulceration, GI bleeding.
* **Hematologic:** Increased bleeding risk, bruising, prolonged bleeding time.
* **Hypersensitivity:** Bronchospasm (especially in aspirin-sensitive asthmatics), urticaria, angioedema.
* **Ototoxicity:** Tinnitus, hearing loss (more common with higher doses).
* **Reye's Syndrome:** In children and adolescents with viral illnesses.
### Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** May reduce antihypertensive efficacy and increase risk of renal dysfunction.
* **Methotrexate:** May increase methotrexate toxicity.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
* **Alcohol:** Increased risk of GI irritation and bleeding.
### Monitoring
* **Signs and symptoms of GI bleeding:** Melena, hematemesis, abdominal pain.
* **Bleeding:** Easy bruising, epistaxis, prolonged bleeding from cuts.
* **Renal function:** Particularly in patients with risk factors or on long-term therapy.
* **Tinnitus:** Can be an early sign of toxicity.
### Clinical Pearls
* The enteric coating allows for once-daily dosing for cardioprotection and may reduce immediate gastric upset, but does not eliminate the risk of GI bleeding or ulceration, especially with long-term use or higher doses.
* Aspirin should be swallowed whole and not crushed, chewed, or broken to preserve the enteric coating.
* For acute pain or fever, immediate-release aspirin formulations may be preferred for faster onset of action.
* The decision to use aspirin for primary cardiovascular prevention is complex and should be based on a thorough risk-benefit assessment.
***
*Disclaimer: This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines before making any treatment decisions.*
